Analytical Lens: Exploring Exact Sciences Corp. (EXAS)’s Financial Story Through Ratios

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Exact Sciences Corp. (NASDAQ: EXAS) was $68.12 for the day, up 3.27% from the previous closing price of $65.96. In other words, the price has increased by $3.27 from its previous closing price. On the day, 1.62 million shares were traded. EXAS stock price reached its highest trading level at $68.17 during the session, while it also had its lowest trading level at $65.0982.

Ratios:

Our analysis of EXAS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 2.17. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.78.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Overweight rating and assigned the stock a target price of $75.

On June 27, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $70.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 18 ’24 when Baranick Brian sold 929 shares for $70.00 per share. The transaction valued at 65,030 led to the insider holds 13,687 shares of the business.

Baranick Brian bought 929 shares of EXAS for $65,030 on Sep 18 ’24. On May 01 ’24, another insider, COWARD D SCOTT, who serves as the Director of the company, sold 67 shares for $60.15 each. As a result, the insider received 4,030 and left with 44,644 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 12586532864 and an Enterprise Value of 14423672832. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.82 while its Price-to-Book (P/B) ratio in mrq is 3.94. Its current Enterprise Value per Revenue stands at 5.522 whereas that against EBITDA is -209.339.

Stock Price History:

Over the past 52 weeks, EXAS has reached a high of $79.62, while it has fallen to a 52-week low of $40.62. The 50-Day Moving Average of the stock is 15.42%, while the 200-Day Moving Average is calculated to be 15.62%.

Shares Statistics:

EXAS traded an average of 2.65M shares per day over the past three months and 2374750 shares per day over the past ten days. A total of 184.77M shares are outstanding, with a floating share count of 181.98M. Insiders hold about 1.51% of the company’s shares, while institutions hold 97.28% stake in the company. Shares short for EXAS as of 1726185600 were 16419544 with a Short Ratio of 6.19, compared to 1723680000 on 13815277. Therefore, it implies a Short% of Shares Outstanding of 16419544 and a Short% of Float of 8.9700006.

Most Popular